Home
/
VitaNova Life Sciences Corp
/
Financials
/
Quarterly
VitaNova Life Sciences Corp — Quarterly Financials
Quarterly figures from SEC EDGAR XBRL filings (10-Q)
These figures are extracted from XBRL-tagged quarterly reports (10-Q) that VitaNova Life Sciences Corp filed with the SEC. Values are as reported for each individual quarter (Q1, Q2, Q3, Q4) — not cumulative year-to-date. Negative figures indicate a loss.
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2024
Jan 31, 2024
$26.1K
Mar 11, 2024
Q2
2024
Oct 31, 2023
$0
Dec 15, 2023
Q1
2024
Jul 31, 2023
$0
Sep 14, 2023
Q3
2024
Jan 31, 2023
$10.0K
Mar 11, 2024
Q2
2024
Oct 31, 2022
$10.0K
Dec 15, 2023
Q1
2024
Jul 31, 2022
$15.0K
Sep 14, 2023
Q3
2023
Jan 31, 2022
$30.0K
Feb 16, 2023
Q2
2023
Oct 31, 2021
$45.0K
Nov 14, 2022
Q1
2022
Jul 31, 2021
$0
Sep 1, 2022
Q3
2022
Jan 31, 2021
$0
Feb 17, 2022
Q2
2021
Oct 31, 2020
$0
Nov 10, 2021
Q1
2022
Jul 31, 2020
$0
Aug 20, 2021
Q3
2021
Jan 31, 2020
$0
Jun 21, 2021
Q2
2021
Oct 31, 2019
$0
Nov 25, 2020
Q1
2021
Jul 31, 2019
$0
Sep 18, 2020
Q3
2020
Jan 31, 2019
$0
Mar 20, 2020
Q2
2020
Oct 31, 2018
$0
Dec 6, 2019
Q1
2020
Jul 31, 2018
$0
Sep 12, 2019
Q3
2019
Jan 31, 2018
$0
Mar 15, 2019
Q2
2019
Oct 31, 2017
$0
Dec 18, 2018
Revenue — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
$709.6K
Mar 16, 2026
Q2
2026
Oct 31, 2025
$427.1K
Dec 15, 2025
Q1
2026
Jul 31, 2025
$103.9K
Sep 12, 2025
Q3
2026
Jan 31, 2025
$308.3K
Mar 16, 2026
Q2
2026
Oct 31, 2024
$292.1K
Dec 15, 2025
Q1
2026
Jul 31, 2024
$108.5K
Sep 12, 2025
Q3
2025
Jan 31, 2024
$26.1K
Mar 17, 2025
Q2
2025
Oct 31, 2023
$0
Dec 13, 2024
Q1
2025
Jul 31, 2023
$0
Sep 10, 2024
Net Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
($44.4K)
Mar 16, 2026
Q3
2026
Oct 31, 2025
$35.8K
Mar 16, 2026
Q2
2026
Oct 31, 2025
$35.8K
Dec 15, 2025
Q1
2026
Jul 31, 2025
($46.3K)
Sep 12, 2025
Q3
2026
Jul 31, 2025
($46.3K)
Mar 16, 2026
Q2
2026
Jul 31, 2025
($46.3K)
Dec 15, 2025
Q3
2026
Jan 31, 2025
$73.0K
Mar 16, 2026
Q3
2026
Oct 31, 2024
$32.6K
Mar 16, 2026
Q2
2026
Oct 31, 2024
$32.6K
Dec 15, 2025
Q2
2026
Jul 31, 2024
($55.2K)
Dec 15, 2025
Q1
2026
Jul 31, 2024
($55.2K)
Sep 12, 2025
Q3
2026
Jul 31, 2024
($55.2K)
Mar 16, 2026
Q3
2025
Jan 31, 2024
$5.9K
Mar 17, 2025
Q2
2025
Oct 31, 2023
($8.8K)
Dec 13, 2024
Q3
2025
Oct 31, 2023
($8.8K)
Mar 17, 2025
Q3
2025
Jul 31, 2023
($24.2K)
Mar 17, 2025
Q2
2025
Jul 31, 2023
($24.2K)
Dec 13, 2024
Q1
2025
Jul 31, 2023
($24.2K)
Sep 10, 2024
Q3
2024
Jan 31, 2023
($24.6K)
Mar 11, 2024
Q3
2024
Oct 31, 2022
$2.6K
Mar 11, 2024
Operating Income — By Quarter
Quarter
Fiscal Year
Period End
Value
Filed
Q3
2026
Jan 31, 2026
$46.7K
Mar 16, 2026
Q2
2026
Oct 31, 2025
$99.2K
Dec 15, 2025
Q1
2026
Jul 31, 2025
($32.4K)
Sep 12, 2025
Q3
2026
Jan 31, 2025
$108.9K
Mar 16, 2026
Q2
2026
Oct 31, 2024
$62.6K
Dec 15, 2025
Q1
2026
Jul 31, 2024
($45.4K)
Sep 12, 2025
Q3
2025
Jan 31, 2024
$5.9K
Mar 17, 2025
Q2
2025
Oct 31, 2023
($8.8K)
Dec 13, 2024
Q1
2024
Jul 31, 2023
($24.2K)
Sep 14, 2023
Q1
2024
Jul 31, 2022
$2.1K
Sep 14, 2023
Q2
2021
Oct 31, 2021
($30.0K)
Nov 10, 2021
Q1
2022
Jul 31, 2021
($10.5K)
Sep 1, 2022
Q3
2021
Jan 31, 2021
($2.9K)
Jun 21, 2021
Q2
2021
Oct 31, 2020
($12.4K)
Nov 10, 2021
Q1
2022
Jul 31, 2020
($11.2K)
Aug 20, 2021
Q3
2021
Jan 31, 2020
($6.6K)
Jun 21, 2021
Q2
2021
Oct 31, 2019
($19.5K)
Nov 25, 2020
Q1
2021
Jul 31, 2019
($19.9K)
Sep 18, 2020
Q3
2020
Jan 31, 2019
($36.7K)
Mar 20, 2020
Q2
2020
Oct 31, 2018
($8.1K)
Dec 6, 2019